Company intelligence / Profile preview

MBK Partners

Seoul, Seoul, South Koreambkpartnerslp.com ↗

Ownership: Private
Employees: ~99
Development stage: Other

Overview

MBK Partners is the largest independent North Asia-focused private equity firm with over $30 billion under management. It invests across multiple industries—including healthcare and pharmaceuticals—by acquiring controlling stakes in leading companies. Recent major deals include the acquisition of Geo-Young, Korea’s top pharmaceutical wholesaler, and Alinamin Pharmaceutical in Japan. The firm is currently bidding for CJ CheilJedang’s bio business division[4][6][9].

Industry: Investors

Beyond the preview

Go deeper on MBK Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MBK Partners.

Explore the full profile